Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Weaver, Akshay Vaishnaw, Peter Francis, Michael Catelani, Sigma-Aldrich


People in the News

Sirna Therapeutics said this week that it has named Gregory Weaver as CFO.

Weaver replaces Martin Schmieg, who resigned from the company last year.

According to Sirna, Weaver most recently served as CFO of Nastech Pharmaceutical. Before that, he was CFO of Ilex Oncology. He has a BS from Trinity University and an MBA from Boston College Graduate School of Management.

Alnylam Pharmaceuticals said this week that Akshay Vaishnaw has become the company's vice president of clinical research.

Vaishnaw comes to Alnylam from Biogen Idec, where he was most recently senior director of translational medicine. He holds an MD from the University of Wales College of Medicine, a PhD from the University of London, and an executive MBA from Harvard Business School.

Benitec this week named two new directors.

The company said Peter Francis, a partner at the Australian law firm of Francis Abourizk Lightowlers, has been appointed as a non-executive director.

Additionally, Michael Catelani, the company's CFO, has been appointed as an executive director.


Products & Services

Sigma-Aldrich has recently introduced the Mission TRC shRNA human tumor suppressor gene family, an shRNA gene family set in lentiviral format.

The suppressors are also available as bacterial glycerol stocks, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.